View
Morning Plenary Presentations (7mb pdf)
View
Regulatory Breakout Presentations (pdf)
View
Starting Up Breakout Presentations (pdf)
View
Workforce/Education Breakout Presentations (pdf)
Morning
8am: Registration, Breakfast & Networking
Plenary Session
- 9:00am: Opening Remarks from BioOhio President & CEO Tony Dennis
- 9:30am: 2020 Visionaries, industry experts current trends and future opportunities in their respective niches
- Personalized Medicine: Ohio State University Center for Personalized Health Care Executive Director Dr. Clay Marsh
- Diagnostics: Quidel President & CEO Doug Bryant
- Regenerative Medicine: Athersys CEO Gil Van Bokkelen
- Cardiovascular: Global Cardiovascular Innovation Center (Cleveland Clinic) Managing Director Mark Low
- 11:35am: Keynote, BIO President & CEO Jim Greenwood discusses the future of biotech and the bioscience industry
~ Lunch in Atrium around 12:30pm ~
Breakout Sessions
1:30pm - 4:45pm
- Workforce & Education: one segment will analyze how industry can better utilize and customize community college programs for workforce, and one segment will discuss how Ohio’s undergraduate and graduate programs can be more responsive to human resource needs in the biomedical industry.
- Panel 1: Larry Miller, Columbus State C.C.; Michelle Hartley, WIL Research; Ann Wilson, Roxane Labs (Boehringer Ingelheim)
- Panel 2: Jack Bantle, Wright State University; Stacia Edwards, Ohio Board of Regents; Patrick Gardner, Battelle; Joel Simon, CAEL
- chaired/moderated by Sr. Director, Workforce & Education Bill Tacon
- Starting Up: informative series of panels for entrepreneurs and emerging companies on how to launch a bioscience/biomedical company, commercialize technology, and get to market, while highlighting helpful resources available throughout Ohio.
- George Proicou and Allison Finkelstein, TechColumbus
- Jan Rosenbaum and Rick D'Augustine, CincyTechUSA
- Jim Weisman, BioEnterprise, and Michael Lang, JumpStart Ventures
- Joseph Gardner, Akebia Therapeutics
- Jon Klotz, Rocket Ventures
- Jeff Wiseman, Edison Biotechnology Institute
- Ray Hagerman, Dayton Development Coalition
- chaired/moderated by BioOhio V.P./COO John Lewis
- Regulatory Forum: FDA staff and Industry representatives serve as panelists. Topics will include: considering 510(k)s through the quality system; utilizing ISO 13485 audits in lieu of FDA Inspections; Overview of FDA inspections, and more.
- Gina Brackett, Compliance Officer, Medical Device Specialist, FDA, Office of Regulatory Affairs
- Ben Dastoli, FDA Investigator, Brunswick Resident Post
- Laureen Geniusz, FDA Investigator, Brunswick Resident Post
- Joseph Vinhais, Sr. Director Regulatory Affairs and Quality, Philips Medical
- Carroll Martin, Regulatory Affairs Manager, US Endoscopy
- Tom Bolton, Manager, Regulatory Affairs, Aptalis Pharma
- Laura Green, VP Regulatory Compliance and Quality, REU Associates
4:45pm - around 7:00pm
Early Evening Reception and
Silent Auction
Featuring heavy hors d'oeuvres and an open bar. Proceeds from the silent auction will benefit The BioOhio Scholarship Fund.
Auction items include Registration to the 2012 BIO International Convention, and Ohio-centric items like signed pieces from Archie Griffin, Craig Krenzel, and The Black Keys, Cincinnati Reds tickets, Columbus Crew tickets, passes to the Columbus Zoo and The Wilds, Donatos Pizza, COSI tickets, and more.